Christina Lake Cannabis Corp.

(CLCFF.PK) (CLC.CN)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

CLC Receives CAD $129,000 Purchase Order for Distillate Oil from a Licensed Producer with Distribution in Multiple Canadian Provinces

Vancouver, BC – MAY 4, 2021 Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce that it has received its first purchase order for a commercial quantity of distillate oil valued at CAD $129,000 from a Canadian licensed producer whose products are distributed in several provinces (the “Purchaser”). Under the terms of the purchase order, the identity of the Purchaser cannot be publicized for competitive reasons. The distillate oils are to be used for the production of vape formulation, a category in which the Purchaser is an established player. The quantity ordered from CLC by the Purchaser is approximately one third of their monthly purchase volume of distillate oils. As the Company has now consistently maintained potency levels in the 90% range for the distillate oils it produces, CLC’s management is confident that it could continue supplying to the Purchaser on an ongoing basis, with the opportunity to provide greater quantities as needed.

 

In the 2020 growing season, Christina Lake Cannabis’ inaugural crop grown naturally under sunlight amounted to nearly double its initial forecasts, with 32,500 kg / 71,650 lb of dried cannabis ultimately harvested. In a press release dated January 13, 2021, the Company announced it was beginning to produce its first ultra-high potency distillate oils, which typically contain tetrahydrocannabinol (“THC”) concentrations of 90% or greater and are used as ingredients in a product formulation as opposed to being used as a standalone cannabis product. In a March 31, 2021 press release, the Company also announced it had nearly tripled its capacity for extraction with the cannabis industry’s first installation of the Vitalis Cosolvent Injection System. This enhancement enables the Company to consistently process more than 250 kg / 551 lb of biomass per day, which is an important consideration in light of CLC’s pivot towards fully integrated production from cultivation to extraction.

 

After its inaugural growing season, Christina Lake Cannabis has made its first sale for a commercial quantity of distillate oil in the amount of CAD $129,000. The Purchaser is an established industry player in several cannabis categories to include vaping, which is one of many potential applications for distillate oils.

 

Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.

 

Christina Lake Cannabis Chief Executive Officer Joel Dumaresq commented, “Distillates are in demand in the Canadian cannabis market because of their versatility. There are possible applications in medicinal products, food and beverage, personal care, vaping, and many other categories. The Purchaser has a broad reach in various cannabis segments to include vaping, for which they are an esteemed player. Through our industry relationships, we were able to come to an agreement with the Purchaser in which they recognized the value in both our product and our fully integrated operations, which can enable them to receive a consistent supply of high quality distillates grown under sunlight using our unique cannabis strains made with proprietary genetics. We look forward to getting feedback from the Purchaser and their end-user clientele, and aspire to form a long-term supplier relationship with them as we begin to build a market position as a supplier of cannabis extracts with complete visibility ‘from soil to oil’ to ensure top-notch quality of our finished product.”

 

About Christina Lake Cannabis Corp.

 

Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company.

 

On behalf of Christina Lake Cannabis Corp.:

 

“Joel Dumaresq”

 

Joel Dumaresq, CEO and Director

 

For more information about CLC, please visit: www.christinalakecannabis.com

 

Jamie Frawley

Investor Relations and Media Inquiries

jamie@clcannabis.com

416-268-9432

 

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

 

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com.

 

Statement Regarding Third-Party Investor Relations Firms

 

Disclosures relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company’s profile on http://sedar.com.

 

"From Seed to Sale": Fully Integrated Production Chain can Provide Unique Advantages to Christina Lake Cannabis in Commercializing Distillate Oils

Vancouver, BC – February 1, 2021 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that one of its cannabis distillate oils has been certified to have a tetrahydrocannabinol (“THC”) concentration of 90.3% based on a certificate of analysis dated January 15, 2021 from a testing laboratory accredited by Health Canada. The Company recently announced its intent to primarily focus on producing cannabis distillate oils by extracting from its 2020 harvest of 32,500 kg / 71,650 lb of biomass grown under natural sunlight. Based on market demand for distillate oils, which typically contain THC concentrations in excess of 90%, the Company believes it is uniquely positioned in the cannabis marketplace to be a competitive supplier of distillate oils. Additionally, the Company is planning to blend cannabis-derived terpenes with its distillate oils, a combination which has only recently been requested in the Canadian cannabis industry despite being relatively common in other markets.

 

As a fully integrated producer of cannabis oils, the Company is favourably situated in the Canadian cannabis industry on account of its control over and visibility into the production chain. CLC has a genetic databank consisting of over 100 proprietary cannabis strains and a total inventory of over 600,000 seeds, which it began cultivating outdoors last spring at its facility in Christina Lake, British Columbia with over 950,000 square feet / 88,258 square metres of outdoor grow space. After harvesting and processing the crop, the Company then extracts oils from its dried biomass using its Vitalis R-200 CO2 extraction machine. This year, the Company has been successful in producing commercial quantities of market-ready winterized cannabis oil with distinct terpene profiles, which are sought-after for use in recreational products under Cannabis 2.0 for adult consumers ( e.g. , vapes, edibles, topicals) as well as in medicinal products.

 

Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.

 

In CLC’s January 13, 2021 press release, it was announced that the Company was beginning to produce ultra-high potency cannabis distillate oils, samples of which are presently undergoing independent third-party assessment of THC levels and other metrics. Distillate oils are not commonly used as a standalone product, but rather as an ingredient in products which could be enhanced through the addition of concentrated THC ( e.g. , food and beverage, personal care, cosmetics). Although the ability to produce cannabis distillate oils is not unique in and of itself, the Company benefits from several advantages it has as a fully integrated producer which can allow for lower risk, above-average profit margins, and greater supervision.

 

Cost of Raw Materials: Cultivating cannabis outdoors naturally using sunlight allows for substantially lower costs compared to growing in greenhouses or indoors. Given the ratio of dried biomass needed for each millilitre of cannabis oil, even small differences in the cost of biomass can have a significant effect on the profitability of a producer of cannabis extracts.

 

Robust Supply: Because the exact yield rate of distillate oil from dried biomass is not always known, producers of cannabis extracts often risk depleting their supply in the event that yields are lower than expected. As the Company’s inaugural harvest garnered 32,500 kg / 71,650 lb of biomass, CLC possesses a sufficient supply of raw material to handle this risk without a significant effect on profitability.

 

Extraction Costs: Extraction is a function that is typically outsourced by cannabis producers, which tends to be more costly than extracting in-house. The Company owns its Vitalis R-200 CO2 extraction machine and all ancillary equipment, and has extraction personnel on staff. As such, the Company’s relatively low costs of extraction could prove advantageous in reducing CLC’s net cost of producing cannabis distillate oils.

 

In-House Visibility: Another disadvantage of outsourcing cannabis extraction to a third party is a lack of ongoing visibility into the processes. Observations made during each step of the way from initial extraction to final distillation are crucial to ensuring a consistent and high-quality finished product, especially when controlling for operational variables and unique properties of specific strains. CLC’s extraction workflows are designed to gather insights in great depth, which can be analyzed collaboratively to make cultivation and business decisions based on observations from empirical data collected during extraction.

 

Joel Dumaresq, Chief Executive Officer and a director of the Company commented, “Part of our vision with Christina Lake Cannabis was not just to maximize the advantages that come from growing outdoors, but also integrating as much as we can into our in-house operations so that we can do things other licensed producers cannot necessarily do. There are many moving parts to any agricultural product ranging from the seed, to the setting in which it is grown, to techniques for cultivation, to harvesting, to post-harvest activities such as extraction. We have sought to bring all of this in house which can enable us not only to reduce costs, but also to oversee each and every step to ensure consistent quality. As we work towards making our first sales of cannabis extracts, it is becoming clear that we have done many things right, and we are confident that market reception could reflect this and give us the opportunity to further optimize our strategies for our second year of growing and beyond.”

 

About Christina Lake Cannabis Corp.

 

Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act . It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company.

 

On behalf of Christina Lake Cannabis Corp.:

 

“Joel Dumaresq”

Joel Dumaresq, CEO and Director

For more information about CLC, please visit: www.christinalakecannabis.com

 

Jamie Frawley
Investor Relations and Media Inquiries
jamie@clcannabis.com
416-268-9432

 

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

 

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com .

 

Statement Regarding Third-Party Investor Relations Firms

 

Disclosures relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company’s profile on http://sedar.com .

 

Source:  Christina Lake Cannabis Corp

Christina Lake Cannabis Announces 2021 Expansion and Crop Allocation for Upcoming Growing Season

Vancouver, BC – January 25, 2021 – Christina Lake Cannabis Corp. (OTCPK: CLCFF) (CSE: CLC) (FRANKFURT: CLB), (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce that its executive management and its team of Master Growers have agreed upon a provisional crop allocation structure for the 2021 growing season. Based on the 2020 performance of the Company’s proprietary cannabis strains, which are genetically optimized for outdoor growth under natural sunlight, CLC has selected seven strains which would comprise approximately 90% of its 2021 crop. Additionally, the Company has elected to trial the outdoor performance of 49 other cannabis strains from CLC’s seed bank and plant portfolio, which would comprise the remaining 10% of the Company’s planned crop for 2021.

 

Although higher ratios of experimental growth are common in the cannabis industry, the Company is taking a conservative approach to its allocation for this year by heavily favouring strains in which CLC has the greatest degree of confidence based on previous results. The Company intends to continue focusing on extraction to produce winterized oils and distillates, which are presently in high demand for uses in medicinal applications as well as consumer packaged goods under “Cannabis 2.0”.

 

In its December 18, 2020 press release, CLC shared details about its genetic databank which consists of more than 600,000 seeds and over 100 different proprietary strains of cannabis. Over a period of approximately three years, the Company experimented with combining genetics to optimize the properties of a given plant’s biomass when grown under sunlight. These proprietary formulations are engineered with an objective of maximizing specific elements of a given cannabis plant (or their respective extracts) such as tetrahydrocannabinol (“THC”) content and terpene profiles.

 

During trial periods of outdoor cultivation, the Company’s Master Growers meticulously track the growth and performance of each proprietary strain, noting any areas of concern such as mildew or susceptibility to pests, as well as its flowering patterns and the plant’s response to certain nutrients. Although the Company’s primary objective is to cultivate cannabis for extractions with high THC content, certain strains with lower THC levels have been chosen for their highly desirable terpene profiles, which can be strategically utilized in specific products for end users.

 

Certain strains of cannabis grown by CLC have demonstrated the ability to survive even during freezing temperatures in the winter

 

Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.

 

For the 2021 growing season, CLC intends to utilize more land than it did in 2020 to cultivate a total of 56 strategically allocated strains. In addition to strains that were successfully grown last year, which will comprise approximately 60% of the Company’s 2021 crop, the Company is also introducing three strains that have already undergone a rigorous two-year testing cycle to confirm their suitability for commercial-scale growth. About 10% of the Company’s planned crop for 2021 is to consist of experimental strains, most of which have already passed the first year of the testing cycle and some of which have demonstrated THC content of 25% or higher, well above the average THC content of CLC’s 2020 crop.

 

During the 2020 growing season, approximately 75% of the Company’s plants were physically supported by latticework frames known as trellises. Because the trellises appear to have been beneficial to the health of the Company’s plants, CLC intends to install trellises for all of its plants in an effort to further improve its output in 2021, in both quantitative and qualitative terms.

 

Joel Dumaresq, Chief Executive Officer and a Director of the Company commented, “The value we create in cultivating cannabis is by no means limited to growing plants outdoors in an optimal climate such as that of Christina Lake. In fact, the proprietary strains of cannabis that we have developed in-house to capitalize upon the environmental advantages we benefit from are arguably the backbone of our enterprise because they enable us to maximize our yields of elements such as THC and terpenes based on our discretion in accordance with market demand. Our integrated business model of cultivation, extraction, and R&D is unique in the Canadian marketplace, and I believe that by strategically allocating proven strains and high-THC experimental strains, we can sustain a reliable and predictable rate of output. In addition to the expanded cultivation area, the possibility of being able to ‘turn over’ certain strains more than once in the growing season, and our increased focus upon strains with higher THC levels, our internal calculations indicate that the overall 2021 harvest yield could expand by 35% or more over the 2020 harvest yield.”

 

About Christina Lake Cannabis Corp.

 

Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company.

 

On behalf of Christina Lake Cannabis Corp.:

 

“Joel Dumaresq”

 

Joel Dumaresq, CEO and Director

 

For more information about CLC, please visit: www.christinalakecannabis.com

 

Jamie Frawley

Investor Relations

jamie@clcannabis.com

416-268-9432

 

Jordan Owens

Media Inquiries

jordan.owens@hkstrategies.ca

236-818-5969

 

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

 

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com.

 

Statement Regarding Third-Party Investor Relations Firms

 

Disclosures relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company’s profile on http://sedar.com.

 

SOURCE:  Christina Lake Cannabis Corp

Christina Lake Cannabis Announces 2021 Expansion and Crop Allocation for Upcoming Growing Season

Vancouver, BC – January 22, 2021 – Christina Lake Cannabis Corp. (CSE:CLC) (OTCPK: CLCFF) (the “Company” or “CLC” or “Christina Lake Cannabis”)  is pleased to announce that its executive management and its team of Master Growers have agreed upon a provisional crop allocation structure for the 2021 growing season. Based on the 2020 performance of the Company’s proprietary cannabis strains, which are genetically optimized for outdoor growth under natural sunlight, CLC has selected seven strains which would comprise approximately 90% of its 2021 crop. Additionally, the Company has elected to trial the outdoor performance of 49 other cannabis strains from CLC’s seed bank and plant portfolio, which would comprise the remaining 10% of the Company’s planned crop for 2021.

 

Although higher ratios of experimental growth are common in the cannabis industry, the Company is taking a conservative approach to its allocation for this year by heavily favouring strains in which CLC has the greatest degree of confidence based on previous results. The Company intends to continue focusing on extraction to produce winterized oils and distillates, which are presently in high demand for uses in medicinal applications as well as consumer packaged goods under “Cannabis 2.0”.

 

In its December 18, 2020 press release, CLC shared details about its genetic databank which consists of more than 600,000 seeds and over 100 different proprietary strains of cannabis. Over a period of approximately three years, the Company experimented with combining genetics to optimize the properties of a given plant’s biomass when grown under sunlight. These proprietary formulations are engineered with an objective of maximizing specific elements of a given cannabis plant (or their respective extracts) such as tetrahydrocannabinol (“THC”) content and terpene profiles.

 

During trial periods of outdoor cultivation, the Company’s Master Growers meticulously track the growth and performance of each proprietary strain, noting any areas of concern such as mildew or susceptibility to pests, as well as its flowering patterns and the plant’s response to certain nutrients. Although the Company’s primary objective is to cultivate cannabis for extractions with high THC content, certain strains with lower THC levels have been chosen for their highly desirable terpene profiles, which can be strategically utilized in specific products for end users.

 

Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.

 

For the 2021 growing season, CLC intends to utilize more land than it did in 2020 to cultivate a total of 56 strategically allocated strains. In addition to strains that were successfully grown last year, which will comprise approximately 60% of the Company’s 2021 crop, the Company is also introducing three strains that have already undergone a rigorous two-year testing cycle to confirm their suitability for commercial-scale growth. About 10% of the Company’s planned crop for 2021 is to consist of experimental strains, most of which have already passed the first year of the testing cycle and some of which have demonstrated THC content of 25% or higher, well above the average THC content of CLC’s 2020 crop.

 

During the 2020 growing season, approximately 75% of the Company’s plants were physically supported by latticework frames known as trellises . Because the trellises appear to have been beneficial to the health of the Company’s plants, CLC intends to install trellises for all of its plants in an effort to further improve its output in 2021, in both quantitative and qualitative terms.

 

Joel Dumaresq, Chief Executive Officer and a Director of the Company commented, “The value we create in cultivating cannabis is by no means limited to growing plants outdoors in an optimal climate such as that of Christina Lake. In fact, the proprietary strains of cannabis that we have developed in-house to capitalize upon the environmental advantages we benefit from are arguably the backbone of our enterprise because they enable us to maximize our yields of elements such as THC and terpenes based on our discretion in accordance with market demand. Our integrated business model of cultivation, extraction, and R&D is unique in the Canadian marketplace, and I believe that by strategically allocating proven strains and high-THC experimental strains, we can sustain a reliable and predictable rate of output. In addition to the expanded cultivation area, the possibility of being able to ‘turn over’ certain strains more than once in the growing season, and our increased focus upon strains with higher THC levels, our internal calculations indicate that the overall 2021 harvest yield could expand by 35% or more over the 2020 harvest yield.”

 

About Christina Lake Cannabis Corp.

 

Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act . It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company.

 

On behalf of Christina Lake Cannabis Corp.:

“Joel Dumaresq”

Joel Dumaresq, CEO and Director

For more information about CLC, please visit: www.christinalakecannabis.com

Jamie Frawley
Investor Relations
jamie@clcannabis.com
416-268-9432

 

Jordan Owens
Media Inquiries
jordan.owens@hkstrategies.ca
236-818-5969

 

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

 

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com .

 

Statement Regarding Third-Party Investor Relations Firms

 

Disclosures relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company’s profile on http://sedar.com .

 

SOURCE:  Christina Lake Cannabis Corp.

Sign Up for FREE
Stock Alerts from

Financial News Media main logo - full color

to be the first to know when this emerging company issues Breaking News!

About Christina Lake Cannabis


A premier producer of high-quality, low-cost, sun-grown cannabis flower, oil cannabinoids and hemp-based extracts and derivatives, serving domestic and international markets.

 


 

 

Uniquely Situated

 

Located between two intersecting valleys near the US border in lower interior British Columbia, our unique climate presents some of the finest grow conditions in North America.

 

Master Growers

 

With decades of outdoor cannabis cultivation experience, our team is delivering premium-quality flower at industry-low production costs.

 

Proprietary Genetics

 

We’ve developed proprietary high-yield, high-potency strains proven to thrive in our unique environment.

 

Onsite Extraction and Processing

 

Ultra-efficient production of premium-quality cannabis extracts suitable for 1000s of possible product applications.

 

Room to Grow

 

99 acres of fully owned expansion space, a strong capital foundation, a scalable low-cost production model, and a variety of domestic and global business opportunities all uniquely position Christina Lake Cannabis Corp for growth.

 

Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) from its existing facility before developing an adjacent 99-acre expansion property, which will bring its annual cultivation footprint to over 4.35 million square feet or over 88,000 kg (194,007 lb) of low-cost, high-quality, sun-grown cannabis.

 

There’s no place like it

Christina Lake operates 32 acres of licensed cultivation space and also fully owns 99 acres of expansion space ideally located near the US border between two intersecting valleys in lower interior British Columbia.

 

Premium flower. Fraction of the cultivation cost.

Relative to the current indoor and greenhouse production companies, outdoor cultivation has a much lower capital and operating cost structure. Outdoor cultivation is less energy and labour intensive and results in a more natural product.

 

Our strains

Originally working under Health Canada’s Medical Licence Program, our master growers have developed proprietary strains selected and bred to thrive in our unique environment. Here are some of the high-yield, terpene and cannabinoid-rich strains we’re growing today:

 

Premium products that command premium prices

CLC’s strategic advantage is our ability to take low-cost outdoor-cultivated cannabis and convert it into a high-quality, THC-rich oil, garnering a premium price.

 

Additional services include tolling dried cannabis into oil and dried hemp into pure CBD oil, R&D analysis and testing, and new product development.

 

SOURCE:  https://christinalakecannabis.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Christina Lake Cannabis Corp. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Christina Lake Cannabis Corp.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.